Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

Recs

2
Player Avatar pwlkrphllp (82.63) Submitted: 12/29/2006 2:36:46 AM : Outperform Start Price: $4.11 THLD Score: +66.74

cancer

Report this Post Reply

Featured Broker Partners


Advertisement